'Mad Money' Uncover...
Health Care: Drugs
Allergan Inc. (AGN: NYSE)
$98.37 -0.08 | -0.08%
05/21/13 - 01:40 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 98.50 |
| 52 Week High | 116.45 |
| 52 Week Low | 81.28 |
| Avg. Daily Vol. (Mil) | 1.78 |
| Beta (3 year) | 0.64 |
| Share Related Items | |
| Mkt Cap (Mil) | 29,195.44 |
| Shares Out (Mil) | 296.40 |
| Float (Mil) | 297.12 |
| Dividend Information | |
| Yield % | 0.20 |
| Annual Dividend | 0.20 |
| Payout Ratio | 7.00 |
| Financial Strength | |
| Quick Ratio | 3.00 |
| Current Ratio | 3.80 |
| LT Debt/ Equity | 0.39 |
| Total Debt / Equity | 0.41 |
| Valuation Ratios | |
| Price Earnings | 34.20 |
| Price/Sales | 4.97 |
| Price/Book | 5.47 |
| Price/Cash Flow | 21.20 |
| Per Share Data | |
| Earnings | 2.88 |
| Sales | 19.82 |
| Book Value | 18.01 |
| Cash Flow | 4.64 |
| Business Summary | |
|---|---|
| Allergan, Inc., is a multi-specialty health care company develops and commercializes innovative pharmaceuticals, biologics and medical devices. | |
| General Information | |
| 2525 Dupont Drive
Irvine, CA 92612 |
|
| www.allergan.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 11100 | |
| CEO: David E.I. Pyott | |
| Short Interest | |
| Current Month (Mil) | 4.94 |
| Previous Month (Mil) | 5.03 |
| Short Interest Ratio (Days) | 4.20 |
| Management Effectiveness | |
| Return on Equity | 20.90 |
| Return on Assets | 12.10 |
| Return on Investments | 15.00 |
| Profitability | |
| Gross Margin | 88.90 |
| EBIT Margin | 27.60 |
| Profit Margin | 19.00 |
Portfolios with AGN
- Portfolio NameUser Type
- ProRay Dalio - Bridgewater Ass...
- ContributorHigh Volume Technicals for ...
- ContributorTechnical Setups for the We...
- UserOil/Gas Feb 2012
- Contributor7 Stocks Set To Rise at Lea...
- UserCLUBCAR47 Portfolio 1
- UserLes's Picks
- ProBridger Management
- ContributorTop 20 Stocks With Large Se...
- ContributorRocket Stocks for the Week ...
Latest AGN Headlines from TheStreet
- 4 Stocks Going Ex-Dividend Tomorrow: PGH, NTI, MAT, AGN 05.20.13 | 10:05 am
- Allergan Stock To Go Ex-dividend Tomorrow (AGN) 05.20.13 | 09:05 am
- AGN, LLY, BIIB, CELG And AMGN, Pushing Health Care Sector Downward 05.16.13 | 01:05 pm
- Allergan Inc. (AGN): Today's Featured Drugs Laggard 05.08.13 | 05:05 pm
- Mad Money Uncovered: Allergan
05.08.13 | 06:05 am - 'Mad Money' Lightning Round: Discover Financial Is Cheap -- Buy It 05.07.13 | 06:05 am
- Cramer's 'Mad Money' Recap: Timing Is Everything 05.06.13 | 08:05 pm
- It's Pipeline That Matters Most 05.04.13 | 04:05 am
- Cramer's Top Stock Picks: AGN BP CRL PRU AIG 05.03.13 | 06:05 am
- Cramer's 'Mad Money' Recap: A New Dawn for Europe? 05.02.13 | 08:05 pm
Press Releases for AGN
- Allergan, Inc. Announces Expiration Of Tender Offer For All Outstanding Shares Of MAP Pharmaceuticals, Inc. And Intent To Exercise Top-Up Option To Effect A Short-Form Merger - Business Wire 03.01.13 | 09:03 am
- FDA Approves Natrelle® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants - Business Wire 02.20.13 | 06:02 pm
- Allergan, Inc. And MAP Pharmaceuticals, Inc. Announce The Federal Trade Commission Has Granted Early Termination Of Waiting Period Under Hart-Scott-Rodino Act - Business Wire 02.07.13 | 09:02 am
- Allergan Reports Fourth Quarter 2012 Operating Results - Business Wire 02.05.13 | 09:02 am
- Allergan Commences Cash Tender Offer For All Outstanding Shares Of MAP Pharmaceuticals - Business Wire 01.31.13 | 09:01 am
- The Law Firm Of Levi & Korsinsky, LLP Notifies Investors Of Claims Of Breaches Of Fiduciary Duty By The Board Of MAP Pharmaceuticals Inc. In Connection With The Sale Of The Company To Allergan Inc. - PR Newswire 01.25.13 | 03:01 pm
- MAP Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Allergan, Inc. - PR Newswire 01.23.13 | 11:01 am
- Allergan, Inc. To Acquire MAP Pharmaceuticals, Inc. - Business Wire 01.22.13 | 08:01 pm
- BOTOX(R) (onabotulinumtoxinA) Receives U.S. Food And Drug Administration Approval For The Treatment Of Overactive Bladder For Adults Who Have An Inadequate Response To Or Are Intolerant Of An Anticholinergic Medication - Business Wire 01.18.13 | 05:01 pm
- Allergan Announces Quarterly Conference Call - Business Wire 01.07.13 | 05:01 pm
Partner Headlines for AGN
- Allergan, Inc. (AGN) Ex-Dividend Date Scheduled for May 21, 2013 - NASDAQ 05.20.13 | 01:05 pm
- Regeneron's Eylea Drives Astounding Q1 Results - Investor's Business Daily 05.10.13 | 06:05 pm
- Leading Biotechs Act Well But Be Careful Not To Chase - Investor's Business Daily 05.06.13 | 06:05 pm
- Starbucks, Huntington Bancshares and Other Stocks Insiders Are Buying - Benzinga 05.04.13 | 10:05 am
- Stocks Rally On Jobs Data; IBD 50 Names Assert Leadership - Investor's Business Daily 05.03.13 | 01:05 pm
- Futures Surge On Jobs Data; Regeneron, Fleetcor Lean Higher - Investor's Business Daily 05.03.13 | 09:05 am
- Stocks Pull Back In Higher Turnover, But Regeneron Soars - Investor's Business Daily 05.01.13 | 04:05 pm
- Stocks In Give-Back Mode; Spirit Air Flies, MasterCard Off - Investor's Business Daily 05.01.13 | 01:05 pm
- Weak Data Hamstring Stocks; Regeneron Pharmaceuticals Soars - Investor's Business Daily 05.01.13 | 12:05 pm
- Pre-Market Earnings Report for May 1, 2013 : MRK, CMCSA, CVS, MA, TWX, AGN, AMT, EXC, VIAB, DVN, DLPH, CHK - NASDAQ 04.30.13 | 08:04 pm
